Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

Survey on Per- and Polyfluoroalkyl Substances (PFASs)

 

EFLM is collaborating with MedTech Europe to collect information on the potential emission and end-of-life of medical technologies containing Per- and polyfluoroalkyl substances (PFASs).

Gathering this information is important, in order to prepare for the reporting requirements that are proposed in the PFAS pre-publication and that can be used during the 6-month public consultation (starting 22 March 2023).

 

THE SURVEY WILL REMAIN OPEN TILL 30 APRIL 2023

 

Thanks in advance for your collaboration!

There are 9 questions in this survey.
 
Close